Administrative gesture for conducting clinical trials of Colchicine on COVID-19 patients: CSIR Kumar Jeetendra | June 12, 2021 The Drugs Controller General of India (DCGI) has given approval to the CSIR and Laxai Life Sciences Private Limited to conduct clinical trial of Colchicine on COVID-19 patients, according to a statement on Saturday. Ram Vishwakarma, the advisor to the CSIR Director General, said Colchicine in combination with standard care will be an important therapeutic …